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Abstract
w3 xThe aim of this study was to investigate the H arachidonic acid metabolism of rat peritoneal macrophages, induced by
 .allergen ovalbumin and the impact of interleukin-4 on this process. We established that ovalbumin induces an increase of
w3 x w3 xH arachidonic acid mobilisation from membrane lipids and of H arachidonic acid catabolism, principally by the
5-lipoxygenase pathway, when the macrophages are sensitized and when serum is present. The allergen effect is not
modified by the presence of interleukin-4 in the culture medium of macrophages 15 h before the allergen challenge. We also
w3 xshowed that, whereas the basal H arachidonic acid metabolism of macrophages from control and actively sensitized rats is
w3 xnot different, interleukin-4 increases the H arachidonic acid mobilisation and catabolism by cyclooxygenase and
5-lipoxygenase pathways in macrophages from control rats although it does not in macrophages from actively sensitized
rats. In macrophages from control rats, the interleukin-4 effect is diminished by the addition of IgEs to their culture
medium. In summary, interleukin-4 has an enhancer effect on the macrophage arachidonic acid catabolism that depends on
the sensitization condition of the cell but that has no consequences on the further increased arachidonic acid metabolism
induced by the allergen. q 1997 Elsevier Science B.V.
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1. Introduction
Numerous cytokines are involved in immediate
hypersensitivity reactions, particularly interleukin-4
 . w xIL-4 1–7 . This cytokine has a predominant role in
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the first phase of the immediate hypersensitivity reac-
tions: the phase of sensitization during which one the
body gains the capacity to specifically recognize an
allergen. During this phase, among other effects, IL-4
induces the synthesis of allergen-specific immuno-
 .globulins E IgEs by B lymphocytes and the expres-
sion on specialized cells of low-affinity receptors for
w xIgEs designated as FcERII or CD23 8 .
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Among these specialized cells, the macrophages,
cells of the phagocytic system, are known to be
involved in the second phase of the immediate hyper-
sensitivity reactions during which the interaction of
the allergen with the specific IgEs bound to their
receptors expressed on the macrophage membrane,
leads to a complex sequence of biochemical events
that produces cellular activation and mediator release.
In this second phase, the macrophages secrete cy-
w x w xtokines 9–11 as well as lysosomal enzymes 12,13 ,
w xplatelet activating factor 14 , superoxide anion
w x15,16 and oxygenated metabolites of arachidonic
 . w xacid AA 16–20 . These metabolites, called
w xeicosanoids 21 and particularly those produced by
w xthe oxygenation of AA by 5-lipoxygenase 22 and
w xcyclooxygenase 23 , take part in the symptomatology
of immediate hypersensitivity by inducing chemoat-
traction for polymorphonuclear leukocytes as well as
pulmonary mucus secretion, vascular permeability and
w xbronchoconstriction 24–29 . Whereas the role of IL-4
in the first phase of the immediate hypersensitivity
reactions is well established, its role and its func-
tional importance in the second phase are not well
known. The aim of this work was to study the effect
of allergen on the AA metabolism of passively or
actively sensitized rat peritoneal macrophages and to
establish whether pretreatment of these macrophages
by IL-4 modifies the effect of allergen during the
second phase of the immediate hypersensitivity reac-
tions.
2. Materials and methods
2.1. Materials
 .Male Brown-Norway rats 220–250 g were pur-
 .chased from Iffa-Credo l’Arbresle, France and were
housed in a sterile environment to avoid spontaneous
sensitization or infection.
w3 x  .Labeled H AA specific activity: 220 Cirmmol
 .was obtained from Amersham France , prostaglandin
and leukotriene radiolabeled standards from Nen
France and the human recombinant interleukin-4
 .usable with rats from Tebu. The culture media were
prepared using Gibco products Cergy-Pontoise,
.France . Protein measurement used an assay kit sup-
 .plied by Sigma St. Quentin Fallavier, France . All
reagents and solvents used were of analytical grade.
2.2. Methods
2.2.1. Acti˝e sensitization of rats
Active sensitization was obtained 14 days after
two subcutaneous injections of 100 mg H AlO and3 3
0.5 mg ovalbumin in 0.5 ml of physiological serum.
One injection was made in the abdomen and the other
w xin a hind foot 30 . In order to verify that the animals
were sensitized by this method, a preliminary experi-
ment was performed. It was shown that two weeks
after this sensitization procedure, all sensitized rats
exposed to an aerosol of 5% ovalbumin developed a
bronchospasm in 20–90 s although none of the con-
trol rats did. The rats used for this preliminary experi-
ment were not used for the following ones.
2.2.2. Preparation of macrophages
Control and sensitized animals were anaesthetized
and exsanguinated. Blood samples were kept to ob-
 .tain sera control and sensitized sera . Peritoneal cells
were then harvested using the technique of Cohn and
w xBenson adjusted to rats 31 . They were collected by
washing the peritoneal cavity with 100 ml of 199
 .medium room temperature with Hank’s salts con-
taining 20 IUrml heparin, 100 mgrml streptomycin
and 100 IUrml penicillin. After centrifugation at
800=g for 10 min at 218C, the cell pellet was
resuspended to obtain a final concentration of 1P106
cellsr300 ml in Dulbecco’s Modified Eagle’s
Medium containing 1% fetal calf serum, 0.6 mM
glutamine, 100 mgrml streptomycin, 100 IUrml
 .penicillin and 3.7 mgrml NaHCO DMEM . Cell3
counting was carried out using non-specific esterase
stain for macrophages which made-up 60% of the
total cellular concentration. The remaining cells were
19% eosinophilic leukocytes, 18% neutrophilic
leukocytes and 3% lymphocytes and mast cells. There
were not any platelets. The cell suspension was placed
 .in a Falcon multiwell plate 300 mlrwell and culti-
vated for 2 h at 378C in an atmosphere of 5% CO in2
air. Then, the non-adherent cells were removed. More
than 98% of the adherent cells were non-specific
esterase positive and had the morphological appear-
ance of macrophages when examined after May-
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Grunwald and Giemsa staining. Macrophage viability
was assessed by a trypan blue exclusion test more
.than 98% of viable macrophages .
[3 ]2.2.3. H AA incorporation and pretreatment of
macrophages by IL-4
The macrophages from control control
. macrophages or sensitized animals sensitized
.macrophages were then cultivated for 15 h at 378C
in an atmosphere of 5% CO in the presence of 5002
w3 xml DMEM containing 1 mCi H AA as described
w xpreviously 19,20 . Half the wells containing control
macrophages and half the wells containing sensitized
macrophages were also cultivated in the presence of
250 IU IL-4.
2.2.4. Allergen challenge
w3 xAt the end of the H AA incorporation period and
IL-4 pretreatment, the culture medium of each well
was removed and kept in order to determinate the
radioactivity not incorporated in the membrane lipids.
Additionally, some control and sensitized wells are
used to study the lipids neutral lipids and phospho-
. w3 xlipids in which the H AA was incorporated in
order to know whether IL-4 modifies the quantity or
w3 xthe quality of the H AA incorporation. The other
wells were rinsed twice with 500 ml DMEM without
fetal calf serum and the control and sensitized
macrophages, pretreated or not by IL-4, were culti-
vated for a further hour at 378C in an atmosphere of
5% CO in 500 ml DMEM or in 500 ml DMEM2
containing either 10 mg ovalbumin, or 10% control
rat serum, or 10% sensitized rat serum, or 10%
control rat serum and 10 mg ovalbumin, or 10%
sensitized rat serum and 10 mg ovalbumin.
2.2.5. Treatment by IgEs
w3 xAt the end of the H AA incorporation period,
some of the control cells pretreated by IL-4 were
cultivated for 1 h in the presence of 5 mg IgEs in 500
ml DMEM per well.
[ 3 ]2.2.6. Extraction and analysis of extracellular H AA
metabolites
After the 1-h incubation period, the culture medium
and the 500 ml DMEM used to wash the cells were
collected and centrifuged at 3000=g for 10 min at
258C. The various AA oxygenation products LTC4-
D4, LTB4, Hetes, 6k-PGF1a , PGD2, PGF2, PGA2-
.PGE2, TxB2 and free AA released by the cells into
the culture medium were measured by thin-layer
 .chromatography TLC and by high-performance liq-
 .uid chromatography HPLC . The results obtained
with both techniques agreed.
TLC analysis was carried out as previously de-
w xscribed 19,20 . Briefly, supernatants were acidified
 .pH 5.0 with 1 N HCl and extracted by chromatogra-
 .phy on SEP-PAK C18 columns Waters . AA
 .metabolites were eluted with methanol 5 ml and
evaporated to dryness under nitrogen. This procedure
was very efficient for extracting AA metabolites,
achieving an extraction yield of approx. 95%. The
residue was dissolved in 10 ml of methanol and
 .applied to thin-layer silica-gel LK-6-DF Whatman
 .which had been previously activated 1 h at 1008C .
The solvent system used to separate prostaglandins,
thromboxanes and leukotrienes was the organic phase
of ethyl acetaterwaterrisooctaneracetic acid
 .110:100:50:20, vrv . The radioactive metabolites
were identified by a Berthold TLC scanner. Results
are expressed in dpmr600 000 macrophages. The
retention time of each metabolite was determined by
co-migration with authentic standards.
HPLC analysis was performed on SEP-PAK C18
w xcolumns as described previously 19,20 . The
eicosanoids were eluted with 5 ml methanol. After
evaporation to dryness under nitrogen, they were
resuspended in acetonitrilerwaterracetic acid
 .35:65:0.6, vrv and subjected to reverse-phase
HPLC. A Hewlett Packard 1090 liquid chromato-
graph was used with a HP 5-mm C18 column 200r4
.mm . The solvent, acetonotrilerwaterracetic acid
buffered to pH 5 with triethylamine, was used at a
1.1-mlrmin flow rate. AA metabolites were eluted
during an initial isocratic phase for 7 min 35:65:0.6,
.vrv , a stepwise gradient increase of acetonitrile to
 .91:9:0.6, vrv for 37 min and during a final iso-
 .cratic phase for 10 min 91:9:0.6, vrv . The radioac-
tivity in the effluent was monitored by a Berthold
LB506D model HPLC radioactivity detector. The
retention time of each metabolite was determined by
co-migration with authentic standards.
2.2.7. Extraction and analysis of membrane
[3 ]H labeled lipids
Lipid analysis was carried out as previously de-
w xscribed 32 . Briefly, after removing the medium, the
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cells were scraped off into 2 ml of methanol using a
rubber policeman and the cell lipids phosphati-
dylcholine, phosphatidylserine, phosphatidylinositol-
phosphatidylethanolamine, phosphatidylglycerol,
cholesteryl esters, monoacylglycerol, diacylglycerol,
.triglycerol were extracted using chloroformrmeth-
 .anolrwater 2:2:2, vrv . The chloroform phase con-
taining the lipids was evaporated to dryness under
nitrogen and the residue was dissolved in 80 ml
chloroform and quantitatively applied to 20=20 cm
 .silica-gel plates LK-6-DF Whatman which had been
previously activated. The plates were run up to 10
.cm with choroformrmethanolrwaterr triethylamine
 .30:34:8:35, vrv for separation of phospholipids,
dried, then run again in the same direction for a
further 6 cm with petroleum etherrdiethyl etherr
 .acetic acid 50:50:1, vrv for separation of neutral
lipids. The radioactive metabolites were identified by
a Berthold TLC Scanner and expressed in
dpmr600 000 macrophages.
2.2.8. Statistical analysis
The results of each set of experiments are ex-
pressed as means"standart error of 3 independent
experiments. Statistical analysis was performed using
a one-way analysis of variance and the multiple
comparisons of each treatment were calculated apply-
w xing the method of Tukey 33 .
3. Results
w3 xAt the end of the H AA incorporation course, the
control and sensitized macrophages incorporated the
w3 xsame quantity of radioactivity and the H labeled
lipids were the same in both types of macrophages.
The mean percentages of incorporated radioactivity
in control and sensitized macrophages were respec-
tively 71.2"5% and 74.4"4.2%. The major labeled
lipids were phosphatidylcholines, phosphatidyl-in-
ositols–phosphatidylethanolamines and cholesteryl
esters.
[3 ]3.1. Effect of the allergen on the H AA metabolism
of control and sensitized macrophages
Control and sensitized macrophages which have
w3 xincorporated H AA for 15 h and which were then
cultivated 1 h in DMEM alone, released tritiated
lipoxygenase and cyclooxygenase metabolites and
free AA into the culture medium. The percentage of
released radioactivity was the same for both types of
macrophages and represented 6.5"0.3% of that in-
corporated. There was no significant difference be-
tween the released eicosanoids and free AA of con-
trol and sensitized macrophages. The major metabo-
lites found in the culture medium of both types of
w3 x w3 xmacrophages are H LTC4-D4, H 6k-PGF1a ,
w3 x w3 xH Hetes and free H AA.
The allergen added to DMEM during the final
hour of culture did not induce any difference of
 .secretion in the control Fig. 1a or in the sensitized
 .macrophages Fig. 1b .
 .The serum from control control serum or sensi-
 .tized sensitized serum animals significantly stimu-
lated the release of tritiated lipoxygenated metabo-
 .lites and free AA by control Fig. 1a and sensitized
 .Fig. 1b macrophages.
In the control macrophages, the allergen stimulated
the secretion of tritiated free AA and lipoxygenated
 .derivates particularly LTC4-D4 and Hetes when
control macrophages were challenged by ovalbumin
 .in the presence of sensitized serum Fig. 1a . This
effect was not observed when control macrophages
were challenged by ovalbumin in the presence of
 .control serum Fig. 1a .
In the sensitized macrophages, the allergen stimu-
lated the secretion of tritiated free AA and lipoxy-
 .genated LTC4-D4 and Hetes metabolites when ei-
ther control or sensitized serum was added to the
culture medium. Thus, both sera allowed the effect of
allergen on the AA metabolism of sensitized
 .macrophages Fig. 1b .
[3 ]3.2. Effect of IL-4 on the basal H AA metabolism
of control and sensitized macrophages
The AA metabolism of control macrophages pre-
w3 xtreated by IL-4 during the 15 h of the H AA
incorporation course was compared with that of con-
trol macrophages untreated by the cytokine. The cy-
w3 xtokine did not modify the quantity of H AA incor-
porated in the membrane lipids 71.2"5% of incor-
porated radioactivity in control macrophages un-
treated by IL-4 and 71.4 " 6.2% in control
.macrophages pretreated by IL-4 or the type of lipids
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Fig. 1. Effect of allergen on free AA and eicosanoid production
of control and sensitized macrophages. As described in Section
 .2.2, macrophages 600000 macrophages in 500 ml DMEM from
 .  .control a or actively sensitized b rats were prelabeled for 15 h
w3 x  .at 378C with H AA 1 mCirwell , washed and then treated for
 .1 h with 500 ml DMEM open bars or with 500 ml DMEM
 .containing 10 mg ovalbumin black squared bars , 10% control
 . rat serum black pointed bars , 10% sensitized rat serum diago-
.nal hatched bars , 10% control rat serum and 10 mg ovalbumin
 .black bars , or 10% sensitized rat serum and 10 mg ovalbumin
 .horizontal hatched bars . After 1-h incubation, supernatant was
removed and free AA and eicosanoid production was analysed.
) )).Each bar is the mean"S.E. of three determinations.
 .P -0.05 0.01 compared to the macrophages treated with
 .  .DMEM alone; v vv P -0.05 0.01 compared to the
macrophages treated by homologous serum without allergen.
w3 xin which the H AA was incorporated. But at the
end of the incorporation course, in the culture medium
of control macrophages pretreated by IL-4, there was
significantly more LTB4 increase of 65.7"4.2%;
. P-0.05 and PGD2 increase of 47.8"3.1%; P-
.0.05 than in the culture medium of untreated control
macrophages. After washing and cultivating cells for
a further hour in DMEM alone, the control
macrophages pretreated by IL-4 secreted twice as
much tritiated free AA, 5-lipoxygenated and cy-
clooxygenated metabolites as the control macrophages
 .untreated by IL-4 Fig. 2a . All the studied
eicosanoids, LTB4, LTC4-D4, Hetes, 6k-PGF1a ,
PGF2, PGA2-E2, PGD2 and TxB2 were significantly
increased.
Fig. 2. Effect of IL-4 on the basal free AA and eicosanoid
production of control and sensitized macrophages. As described
in Section 2.2, macrophages 600000 macrophages in 500 ml
.  .  .DMEM from control a or actively sensitized b rats were
either treated or not with 250 IU IL-4 for 15 h at 378C in the
w3 x  .presence of H AA 1 mCirwell , washed and then cultivated
for 1 h in 500 ml DMEM. After this hour of incubation,
supernatant was removed and free AA and eicosanoid production
 .  .of pretreated black bars or unpretreated open bars macrophages
was analysed. Each bar is the mean"S.E. of three determina-
) )).  .tions. P -0.05 0.01 compared to the unpretreated
macrophages.
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The AA metabolism of sensitized macrophages
w3 xpretreated by IL-4 during the 15 h of the H AA
incorporation course was compared with that of sen-
sitized macrophages untreated by the cytokine. The
w3 xcytokine did not modify either the quantity of H AA
Fig. 3. Effect of IL-4 preteatment on the allergen-induced
eicosanoid production of control and sensitized macrophages. As
described in Section 2.2, macrophages 600000 in 500 ml
.  .  .DMEM from control a or actively sensitized b rats were
w3 x  .prelabeled for 15 h at 378C with H AA 1 mCirwell in the
presence of 250 IU IL-4, washed and then treated for 1 h with
 .500 ml DMEM open bars or with 500 ml DMEM containing 10
 . mg ovalbumin black squared bars , 10% control rat serum black
.  .pointed bars , 10% sensitized rat serum diagonal hatched bars ,
 .10% control rat serum and 10 mg ovalbumin black bars , or 10%
sensitized rat serum and 10 mg ovalbumin horizontal hatched
.bars . After 1-h incubation, supernatant was removed and free
AA and eicosanoid production was analysed. Each bar is the
) )).  .mean"S.E. of three determinations. P -0.05 0.01
compared to the macrophages treated by DMEM alone; v
 .  .vv P -0.05 0.01 compared to the macrophages treated by
homologous serum without allergen.
Fig. 4. Effect of IgEs on the IL-4-induced free AA and eicosanoid
production of control macrophages. As described in Section 2.2,
 .macrophages 600000 macrophages in 500 ml DMEM from
control rats were treated with 250 IU IL-4 for 15 h at 378C in the
w3 x  .presence of H AA 1 mCirwell , washed and then cultivated
for 1 h in 500 ml DMEM either containing diagonal hatched
.  .bars or not black bars 5 mg IgEs. After this hour of incubation,
supernatant was removed and free AA and eicosanoid production
of these macrophages was analysed. Each bar is the mean"S.E.
) )).  .of three determinations. P -0.05 0.01 compared to the
macrophages not cultivated in the presence of IgEs.
incorporated in the membrane lipids 74.4"4.2% of
incorporated radioactivity in sensitized macrophages
untreated by IL-4 and 74.1"3.2% in sensitized
.macrophages pretreated by IL-4 or the type of lipids
w3 xin which the H AA was incorporated. At the end of
the incorporation course, the secretions of free AA
and eicosanoids by untreated and pretreated sensi-
tized macrophages are not different. After washing
and cultivating the cells for a further hour in DMEM
alone the secretions of untreated and pretreated sensi-
tized macrophages are still not significantly different
 .Fig. 2b .
[ 3 ]3.3. Effect of IL-4 on the H AA metabolism induced
by the allergen in control and sensitized macrophages
In control macrophages pretreated by IL-4 during
w3 xthe 15 h of the H AA incorporation course, then
washed and cultivated for 1 h in DMEM alone or in
DMEM containing control or sensitized serum andror
 .allergen Fig. 3a , it is noted firstly, that the control
and sensitized sera increased the secretion of free AA
and 5-lipoxygenated metabolites and secondly, that
the sensitized serum was always necessary for the
w3 xallergen to have an enhancer effect on the H AA
metabolism of IL-4 pretreated control macrophages.
In sensitized macrophages pretreated by IL-4 dur-
w3 xing the 15 h of the H AA incorporation course, then
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washed and cultivated for 1 h in DMEM alone or in
DMEM containing control or sensitized serum andror
 .allergen Fig. 3b , it was also noted firstly, that the
control and sensitized sera increased the secretion of
free AA and 5-lipoxygenated metabolites and sec-
ondly, that control or sensitized serum was always
necessary for the allergen to have an enhancer effect
w3 xon the H AA metabolism of IL-4 pretreated sensi-
tized macrophages.
[3 ]3.4. Effect of IgEs on the IL-4 induced H AA
metabolism of control macrophages
The secretion of tritiated free AA, cyclooxy-
genated and 5-lipoxygenated metabolites of control
macrophages, pretreated by IL-4 during the 15-h
incorporation course then washed and cultivated for
another hour, was significantly decreased when IgEs
 .were added for the final hour of culture Fig. 4 .
4. Discussion
In immediate hypersensitivity reactions, the impor-
tance of IL-4 in the sensitization phase is now well
established. On the other hand, in the second phase of
these reactions, when allergen enters in the organism
once again and initiates physical symptoms, its in-
volvement is not well known. Therefore, our aim was
to study the AA metabolism of rat peritoneal
macrophages during the second phase of the immedi-
ate hypersensitivity reaction induced by allergen
 .ovalbumin challenge of passively or actively oval-
bumin-sensitized macrophages and the impact of IL-4
on this process.
w xAs already demonstrated in previous works 19,20 ,
 .we showed in this study that: 1 isolated and culti-
vated rat peritoneal macrophages produce eicosanoids
 .without any stimulation; 2 this production is ampli-
 .fied by serum; 3 the allergen added alone to the
culture medium of macrophages is not able to stimu-
 .late macrophage eicosanoid secretion; 4 the allergen
increases the eicosanoid secretion of cultivated
macrophages when the cells are sensitized to this
allergen either actively sensitized because coming
directly from a rat actively sensitized to the allergen
or passively sensitized because the macrophages were
cultivated in the presence of serum from an actively
.  .sensitized rat ; and 5 the presence of serum is
always necessary for the allergen to act on the AA
metabolism of sensitized macrophages. So, the peri-
toneal rat macrophages, need to obtain the effect of
allergen on their AA metabolism, a seric factor
whereas a cellular factor induced by the active sensi-
tization of the animal is not absolutely necessary
since the allergen effect can be obtained with pas-
.sively sensitized cells from control rat . This result is
different from that obtained with alveolar
w xmacrophages from guinea-pigs 20 which need to
obtain the effect of the allergen on their AA
metabolism the presence of both factors both in-
duced by the active sensitization of the animals, one
coming from the macrophage and the other from the
.serum . When the peritoneal macrophages come from
an actively sensitized rat, the seric factor is not
necessarily supplied by the active sensitization of the
rat from which the serum came. This seric factor can
be supplied by serum from a control rat. The exact
 .nature of the seric factor s involved has not been
identified. It could be a complement fragment or
w xgrowth factors as we have already reported 19,20 or
a factor that would induce, by the intermediate of the
serum-responsive element, the activation of an imme-
diate-early gene, the expression of which being nec-
w xessary for the transduction signal of the allergen 34 .
As reported above, when added to the culture
medium of sensitized macrophages in presence of
serum, the allergen increases the production of free
AA and lipoxygenated AA metabolites in the culture
medium of the cells. This suggests that the allergen
activates the enzymes necessary for this production,
in particular the lipases that allow the release of AA
from the membrane lipids and the 5-lipoxygenase
that allows the catabolism of free AA into leuko-
trienes. More often, it is a phospholipase A2 that is
involved in the mobilization of the AA from phos-
pholipids, particularly a cytosolic phospholipase A2
w xof 85–110 kDa 35 . However, it cannot be excluded
that the allergen involves either lipases mobilizing
AA from neutral lipids like mono-, di- or triacyl-
.glycerol lipases or other types of phospholipase A2
 .like a phospholipase A2 of lower molecular weight
as it was observed by Balsinde et al. in P388D1
w xmacrophages under the effect of A23187 36 . The
induction by the allergen of an increase of 5-lipo-
xygenated catabolite production suggests that the al-
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lergen also acts on the enzyme 5-lipoxygenase. The
strong involvement of this enzyme in symptomatol-
ogy of immediate hypersensitivity reactions is well
known and it has already been shown, in other types
 .of cells mast cells and polynuclear leukocytes , that
allergen induces the translocation of this enzyme
from the cytosol to the cell membrane and thus its
w xactivity 37,38 . In our study, the allergen does not
have a significant impact on the production of cy-
clooxygenated metabolites. This difference of aller-
gen effects on the activities of 5-lipoxygenase and
cyclooxygenase could suggest that allergen involves
second messengers which favour the first enzyme.
However, because in inflammatory reactions the usual
form of the cyclooxygenase involved is an inducible
w xone 23,39,40 , it cannot be excluded that the short
 .time 1 h of macrophage stimulation by the allergen
in this study does not allow new cyclooxygenase
synthesis to be induced.
The present work demonstrates that the pretreat-
ment of macrophages by IL-4 does not modify the
results that we discussed above. The pretreatment of
macrophages by IL-4 modifies neither the effect of
allergen on the AA metabolism of actively or pas-
sively sensitized macrophages nor the necessity for
the presence of serum to obtain this effect. So, in the
experimental conditions we used, this cytokine does
not appear to be a modulating element of the
macrophage AA metabolism induced by the allergen
during the second phase of immediate hypersensi-
tivity reactions.
We also showed in this work that IL-4 increases
the AA metabolism of the macrophages from control
rats since it has no effect on the macrophages from
actively sensitized animals. The control macrophages
pretreated for 15 h by IL-4 and then cultivated for a
further hour in culture medium containing just 1%
calf fetal serum increased their secretion of free AA
and eicosanoids two-fold. The effect of IL-4 was
w3 xalready observable at the end of the 15-h H AA
incorporation course since there was significantly
w3 xmore LTB4 and PGD2 in the H AA incorporation
medium of pretreated control macrophages than in
the incorporation medium of unpretreated control
macrophages. Because the IL-4 pretreatment of con-
trol cells modified neither the quantity of incorpo-
rated radioactivity nor the type of lipids in which the
w3 xH AA is incorporated, it can be hypothesized that
during the incorporation course, IL-4 induces a
w3 xcatabolism of exogenous H AA without affecting
the acylation processes. So, these results suggest that,
in control macrophages, IL-4 pretreatment increases
the activity andror the expression of the enzymes
involved in AA catabolism such as phospholipase
A2, 5-lipoxygenase and cyclooxygenase. Other au-
thors have already established that IL-4 can act on
the catabolism of AA by acting on the expression of
w x15-lipoxygenase 41–43 . A potential effect of IL-4
on the expression andror the activities of phospholi-
pase A2 and 5-lipoxygenase has, to our knowledge,
not yet been reported.
Unlike macrophages from control rats, IL-4 pre-
treatment did not modify free AA or eicosanoid
secretion in peritoneal macrophages from actively
sensitized rat. This result establishes that active sensi-
tization of the rat modifies the ‘reactivity’ of
macrophages to IL-4 pretreatment. Because during
the sensitization phase of immediate hypersensitivity
reactions the organism acquires allergen-specific IgEs
and IgE receptors such as the CD23, one hypothesis
could be that the difference in the ‘reactivity’ of both
control and sensitized macrophages to IL-4 is due to
the absence or the presence, respectively, of specifics
IgEs bound to their receptors on the surface of the
macrophages. We tested, in the last section of this
work, the effect of IgEs on the AA metabolism
induced by IL-4 pretreatment of control macrophages.
We established that the IgEs decreased the produc-
tion of free AA and eicosanoids of IL-4 pretreated
control cells, suggesting that, during the sensitization
phase, the acquisition and the binding of IgEs at the
surface of the macrophages could modify the initial
‘reactivity ’ of the cells to a further stimulus. Rio et
al. previously demonstrated that the binding of IgEs
on platelets of control or allergic subjects can modify
macrophage functions such as the production of oxy-
w xgenated radicals 44 . The fact that IgEs and their
receptors, in particular the low-affinity one, can have
a regulatory role on the effects of IL-4 has also been
reported in two works in which anti-CD23 antibodies
or IgE-anti-IgE immune complexes can inhibit the
IL-4-induced proliferation of B lymphocytes and the
w xIL-4-induced IgE production 45,46 . The regulatory
role of the IgE binding could occur via the modula-
tion of IL-4 receptor expression at the surface of the
macrophage these receptors can transiently be inter-
( )C. M’Rini et al.rBiochimica et Biophysica Acta 1357 1997 319–328 327
w x.nalized 47 or by an interference of the transduction
signals of IgE receptors and IL-4 receptors. Some
authors have demonstrated interference of CD23 on
the cAMP increase induced by IL-4 in B lympho-
w xcytes 48,49 . These authors have also shown in other
works that cAMP and cGMP are common second
messengers of CD23 and IL-4 receptor in monocytes
w x50 .
An alternative hypothesis could be that the IL-4
effect on the AA metabolism of control macrophages
is not direct but mediated by the modifications in-
duced by the cytokine in particular the expression of
the CD23 which is known to supply soluble frag-
ments. The effects of these CD23 soluble fragments
w xhave most often been studied in B lymphocytes 51
but some authors have demonstrated that they can act
w xon monocyte functions 52 . So in the hypothesis we
report here, the CD23 expressed on the control
macrophage membrane under the effect of IL-4 would
cleave in soluble fragments and then, would bind
again to the macrophage membrane e.g., by a carbo-
.hydrate on a lectin-receptor and would stimulate the
AA metabolism of control macrophages. It is estab-
lished that the binding of a ligand stabilizes the
w xCD23, inhibiting its clivage 53 . So, in sensitized
macrophages, the binding of specifics IgEs would
stabilize the CD23 having the consequence that the
AA metabolism of such macrophages could not be
stimulated because of soluble fragment absence.
What could be the physiological significance of
such a difference in the ‘reactivity’ of control and
sensitized macrophages to an IL-4 pretreatment? It is
established that when the allergen enters the body for
the first time, it induces a lot of processes among
which is the production of IL-4 by activated T helper
w xlymphocytes and mast cells 54 . The IL-4 favors the
response of the organism to the allergen by inducing
specific IgE synthesis and expression of IgE low
w xaffinity receptor CD23 55 . The increase of the
macrophage AA metabolite production that we note
in this study, could amplify this response because of
the properties of the eicosanoids. Some of these
molecules are indeed chemotactic and act as growth
factors for the cells involved in the immune re-
w xsponses 25 . When the newly synthesized IgEs bind
to their receptors, particularly at the surface of the
macrophages, they inhibit, as we shown, the capacity
of these cells to respond to the IL-4 rich environment
and thus, the acquisition of allergen-specific IgEs by
the macrophages and the body would conclude the
sensitization phase.
In conclusion, we showed that IL-4 has, depending
on the sensitization condition of the cells, an effect
on the AA catabolism of rat peritoneal macrophages
although this effect has no consequences on the
allergen-induced AA metabolism of macrophages
during the second phase of hypersensitivity reactions.
Our results attract attention to the sensitization phase
and its consequences on the macrophage maturity.
During this phase, the macrophage functions such as
the AA metabolism are not apparently modified we
have shown that the basal free AA and AA metabo-
lite production of macrophages from control and
.actively sensitized rats is the same . However, the
‘reactivity’ of these cells is altered, suggesting that
the sensitization differentiates the macrophages: the
consequences of this differentiation appearing subse-
quently when the cells are submitted to further stimu-
 .lus as in our study with allergen and IL-4 .
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